PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection

Transplantation

Volumn 86, Issue 6, 2008, Pages 836-844

  Wang, Weigang ^a,d   Carper, Katie ^a   Malone, Frances ^b   Latchman, Yvette ^a,c   Perkins, James ^a   Fu, Yaowen ^d   Reyes, Jorge ^a,b   Li, Wei ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c PUGET SOUND BLOOD CENTER   (United States)

^d JILIN UNIVERSITY   (China)

Author keywords

Acute rejection; Heart transplantation; PD L1

Indexed keywords

ALLOANTIGEN; APOPTOSIS REGULATORY PROTEIN; PROGRAMMED DEATH 1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; B7 ANTIGEN; DIFFERENTIATION ANTIGEN; MEMBRANE PROTEIN; PD 1 ANTIGEN, MOUSE; PD-1 ANTIGEN, MOUSE; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HEART TRANSPLANTATION; HISTOCOMPATIBILITY COMPLEX; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; WILD TYPE; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CD8+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GRAFT REJECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE CULTURE; MOUSE MUTANT; SPLEEN; T LYMPHOCYTE; TIME;

ANIMALS; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HEART TRANSPLANTATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 56049111091     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181861932     Document Type: Article

References (27)

1. Latchman YE, Liang SC, Wu Y, et al. PD-L1-deficient mice show that PD-L1 on T cells, antigen presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci USA 2004; 101: 10691.
2. Keir ME, Liang SC, GuleriaI, et al. Tissue expressionof PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006; 203: 883.
3. Keir ME, Latchman YE, Freeman GJ, et al. Programmed death-1 (PD-1): PD-ligand 1 interactions inhibit TCR-mediated positive selection of thy-mocytes. J Immunol 2005; 175: 7372.
4. Gao W, Demirci G, Strom TB, et al. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation 2003; 76: 994.
5. Sandner SE, Clarkson MR, Salama AD, et al. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol 2005; 174: 3408.
6. Koga N, Suzuki J, Kosuge H, et al. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. qArterioscler Thromb Vasc Biol 2004; 24: 2057.
7. Li W, Carper K, Perkins JD. Enhancement of NKT cells and increase in regulatory T cells results in improved allograft survival. J Surg Res 2006; 134:10.
8. Li W, Fu F, Lu L, et al. Differential effects of exogenous interleukin-10 on cardiac allograft survival: Inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation 1999; 68: 1402.
9. Li W, Lu L, Wang Z, et al. Costimulation blockade promotes the apo-ptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation 2001; 72: 1423.
10. Li W, Zheng XX, Kuhr CS, et al. CTLA4 engagement is required for induction of murine liver transplant spontaneous tolerance. Am J Transplant 2005; 5: 978.
11. Latchman Y, Wood CR, Chernova T, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2: 261.
12. Habicht A, Kewalaramani R, Vu MD, et al. Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo. Am J Transplant 2007; 7: 2683.
13. Wang L, Han R, Hancock WW. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Eur J Immunol 2007; 37: 2983.
14. Dong H, Zhu G, Tamada K, et al. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 2004; 20:327.
15. KanaiT, TotsukaT, UraushiharaK, et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol 2003; 171: 4156.
16. Subudhi SK, Zhou P, Yerian LM, et al. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest 2004; 113:694.
17. Wang S, Bajorath J, Flies DB, et al. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med 2003; 197: 1083.
18. del Rio ML, Penuelas-Rivas G, Dominguez-Perles R, et al. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation. Eur J Immunol 2005; 35: 3545.
19. Butte MJ, Keir ME, Phamduy TB, et al. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007; 27: 111.
20. Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immu-noinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027.
21. Aramaki O, Shirasugi N, Takayama T, et al. Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation 2004; 77:6.
22. Kitazawa Y, Fujino M, Wang Q, et al. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation 2007; 83: 774.
23. Sharma MD, Baban B, Chandler P, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 2007; 117: 2570.
24. Ozkaynak E, Wang L, Goodearl A, et al. Programmed death-1 targeting can promote allograft survival. J Immunol 2002; 169: 6546.
25. Watson MP, George AJ, Larkin DF. Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest Ophthalmol Vis Sci 2006; 47: 3417.
26. Yamazaki T, Akiba H, Iwai H, et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002; 169: 5538.
27. Yu MC, Chen CH, Liang X, et al. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 2004; 40: 1312.